Skip navigation

A trial looking at chemotherapy for male germ cell cancer (TE 23)

Please note this trial is no longer recruiting patients.

This trial is comparing 2 different chemotherapy regimes for male germ cell cancers.

Germ cells are the cells that produce eggs in females and sperm in males. Male germ cell cancers usually develop in the testicles, but can be found in other parts of the body.

Doctors usually treat germ cell cancers with surgery if it is in the testicle, or chemotherapy if it is somewhere else in the body. They usually give a combination of chemotherapy called BEP. This is bleomycin, etoposide and cisplatin.

BEP doesn’t always work well for germ cell cancers that are classed as ‘poor prognosis’. Doctors think a new combination of drugs known as CBOP BEP may work better for these cancers. CBOP BEP is carboplatin, vincristine, bleomycin, etoposide and cisplatin. But all chemotherapy drugs have some side effects, and it is important that patients don’t have treatments they don’t need.

The aim of this trial is to compare BEP and CBOP BEP to see which works better for poor prognosis male germ cell cancer. And to find out more about the side effects.

Recruitment

Start 01/06/2005
End 14/12/2009

Phase

Phase 2

Who can enter

You can enter this trial if you

You cannot enter this trial if you have

  • Had chemotherapy before
  • Any other serious medical condition

Trial design

This is a randomised trial. It will recruit 88 patients into 2 groups. The men taking part will be put into treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in.

If you are in group 1 you will have BEP chemotherapy. You have etoposide and cisplatin daily, for 5 days every 3 weeks. And bleomycin once a week. Each 3 week block is one cycle of chemotherapy. You will have 4 cycles over 12 weeks (3 months).

If you are in group 2 you will have CBOP BEP chemotherapy. You will have treatment for 15 weeks (nearly 4 months) altogether. During the first 4 weeks you have CBOP (carboplatin, bleomycin, vincristine and cisplatin). During weeks 5 and 6 you have BO (bleomycin and vincristine). And during weeks 7 to 15 you have BEP (bleomycin etoposide and cisplatin). Your doctor will explain the exact order of the drugs you will have nearer the time.

Hospital visits

You will see the doctors and have some tests before you take part in this trial. The tests include

You will go to hospital to have chemotherapy. You will need to stay in hospital for part of your treatment. But how often and for how long will depend on which group you are in.

You will have blood tests, a physical examination and a chest X-ray every few weeks before each cycle of chemotherapy. At the end of treatment you have a CT scan, physical examination and some blood tests.

After you finish treatment you will see the doctors every 2 months for a year, every 3 months for another year, and then every 6 months for 3 years. You will have a physical examination, blood tests and a chest X-ray at each visit. You will also have CT scans, but exactly when will depend on the usual practice at your hospital. You will have hearing tests and lung function tests at 1 year.

Side effects

The most common side effects of the drugs used in this trial are

  • A drop in blood cells causing an increased risk of infection, bleeding or bruising problems, tiredness and shortness of breath
  • Feeling or being sick
  • Hair loss
  • Sore mouth
  • Inflammation in the lungs with bleomycin
  • Fever and chills with bleomycin
  • Reduced kidney function with cisplatin (you will have lots of fluids to stop this happening)
  • Reduced hearing of high pitched sounds with cisplatin
  • Numbness and tingling in hands and feet (peripheral neuropathy) with vincristine
  • Stomach pain and constipation with vincristine

There is more information on the following links about the side effects of

Location of trial

CLOSED

For more information

The Information Nurses
Cancer Research UK
Angel Building
407 St John Street
London
EC1V 4AD

Tel: 0808 800 4040
Email: cancer.info@cancer.org.uk

Please note: we cannot help you to join a specific trial. Unless we state otherwise in this trial summary, you must go through your own doctor.

Chief Investigator

Dr R Huddart

Supported by

Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
National Cancer Research Network (NCRN)